Home CardieX Limited

CardieX Limited

ATCOR Granted New Patent by the EPO for for the Company’s Proprietary SphygmoCor ® Technology Used in Cuff-Based Blood Pressure Devices

ATCOR's SphygmoCor® technology is the global standard for the non-invasive measurement of arterial stiffness in medical settings and is in use at all "Top 20 USA Hospitals" and more than over 4500 installations worldwide including major pharmaceutical companies and research institutions such as The Mayo Clinic, GlaxoSmithKline, AstraZeneca, Bayer, Scripps, Johns Hopkins, and Stanford University.